Xynos Konstantinos
SEC CIK 1956241 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Chief Medical Off | 224.2K | — | $681.9K | 15 | 2022-12-01 | 2026-08-10 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 17:05 | 2026-08-10 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $12.97 | -11.4K | 224.2K | -5% | -$148.5K | |
| 2026-05-20 16:18 | 2026-05-18 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $5.08 | -14.0K | 235.7K | -6% | -$71.2K | |
| D | 2026-04-07 21:10 | 2026-04-01 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +50.0K | 249.7K | +25% | $0 |
| 2025-12-19 | 2025-12-19 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +60.0K | 199.7K | +43% | $0 | |
| 2025-11-19 | 2025-11-17 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $9.10 | -7,248 | 139.7K | -5% | -$66.0K | |
| 2025-05-22 | 2025-05-20 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $8.06 | -7,952 | 146.9K | -5% | -$64.1K | |
| D | 2025-04-03 | 2025-04-01 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +45.0K | 154.9K | +41% | $0 |
| 2024-11-20 | 2024-11-18 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $10.78 | -7,246 | 109.9K | -6% | -$78.1K | |
| 2024-06-10 | 2024-06-07 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $7.50 | -15.9K | 117.1K | -12% | -$119.1K | |
| 2024-05-20 | 2024-05-16 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $6.47 | -6,367 | 133.0K | -5% | -$41.2K | |
| D | 2024-04-03 | 2024-04-01 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +26.7K | 139.4K | +24% | $0 |
| 2023-11-17 | 2023-11-16 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $10.92 | -7,313 | 112.7K | -6% | -$79.9K | |
| 2023-05-18 | 2023-05-16 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | S - Sale | $18.05 | -771 | 120.0K | -0.6% | -$13.9K | |
| D | 2023-04-04 | 2023-04-01 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +50.0K | 120.8K | +71% | $0 |
| D | 2022-12-05 | 2022-12-01 | REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Off | A - Grant | $0.00 | +17.5K | 70.8K | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations